Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
32.73B | 43.55B | 44.06B | 44.46B | 43.62B | 39.15B | Gross Profit |
3.87B | 5.29B | 5.41B | 5.46B | 5.00B | 4.23B | EBIT |
313.00M | 464.00M | 505.00M | 886.00M | 628.00M | 190.00M | EBITDA |
491.75M | 858.00M | 838.00M | 1.35B | 870.00M | 529.00M | Net Income Common Stockholders |
190.00M | 314.00M | 345.00M | 732.00M | 448.00M | 274.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
126.00M | 113.00M | 138.00M | 186.00M | 186.00M | 188.00M | Total Assets |
18.15B | 17.23B | 17.78B | 17.19B | 17.17B | 16.45B | Total Debt |
884.00M | 73.00M | 876.00M | 356.00M | 710.00M | 458.00M | Net Debt |
758.00M | -40.00M | 738.00M | 170.00M | 524.00M | 270.00M | Total Liabilities |
5.40B | 4.31B | 4.95B | 4.53B | 4.95B | 4.58B | Stockholders Equity |
12.75B | 12.91B | 12.82B | 12.66B | 12.22B | 11.88B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.08B | -293.00M | 320.00M | -140.00M | 1.27B | Operating Cash Flow |
0.00 | 1.16B | 101.00M | 442.00M | 92.00M | 1.85B | Investing Cash Flow |
0.00 | -158.00M | -452.00M | 72.00M | -238.00M | -579.00M | Financing Cash Flow |
0.00 | -1.02B | 300.00M | -518.00M | 141.00M | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥37.67B | 17.86 | 3.08% | 6.07% | 6.17% | ||
75 Outperform | ¥44.39B | 9.15 | 4.77% | 5.70% | 10.65% | ||
70 Outperform | ¥6.40B | 10.04 | 1.78% | 1.70% | 12.23% | ||
70 Neutral | ¥5.94B | 5.78 | 2.50% | 4.22% | 22.71% | ||
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% | |
63 Neutral | ¥25.61B | 17.53 | 3.34% | 5.69% | 202.27% | ||
62 Neutral | ¥7.01B | 22.32 | 3.13% | -1.16% | -8.99% |